Development and preclinical evaluation of theranostic agents targeting muc16/ca125 and nectin-4 expression in breast, ovarian and pancreatic cancers
| dc.contributor.committeeMember | Kalra, Jay | |
| dc.contributor.committeeMember | Dadachova, Ekaterina | |
| dc.contributor.committeeMember | Freywald, Andrew | |
| dc.contributor.committeeMember | Vizeacoumar, Franco | |
| dc.contributor.committeeMember | Leyton, Jeffrey | |
| dc.creator | Babeker, Hanan | |
| dc.date.accessioned | 2023-09-26T20:13:37Z | |
| dc.date.copyright | 2023 | |
| dc.date.created | 2023-09 | |
| dc.date.issued | 2023-09-26 | |
| dc.date.submitted | September 2023 | |
| dc.date.updated | 2023-09-26T20:13:42Z | |
| dc.description.abstract | This item is under an embargo. Access to the abstract will not be permitted until 2024-09-26 | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.uri | https://hdl.handle.net/10388/15068 | |
| dc.language.iso | en | |
| dc.subject | Antibody-based Theranostics, Radioimmunotherapy | |
| dc.title | Development and preclinical evaluation of theranostic agents targeting muc16/ca125 and nectin-4 expression in breast, ovarian and pancreatic cancers | |
| dc.type | Thesis | |
| dc.type.material | text | |
| local.embargo.lift | 2024-09-26 | |
| local.embargo.terms | 2024-09-26 | |
| thesis.degree.department | Medicine | |
| thesis.degree.discipline | Health Sciences | |
| thesis.degree.grantor | University of Saskatchewan | |
| thesis.degree.level | Doctoral | |
| thesis.degree.name | Doctor of Philosophy (Ph.D.) |